SBIR/STTR Research Award

Anti Inflammatory/Effects of CRF Binding Protein

Award identifier 54443f5b45bdb2839bc2d89eb093ab4ca29f051a98bce9257b5a8bc8c0e42f9eAwarding agency Department of Health and Human Services

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

1995

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Neurocrine Biosciences, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

CRF, a 4l-amino acid peptide, plays a significant role in modulating inflammatory responses throughcoordinated actions in the nervous, endocrine and immune systems. CRF has indirect anti-inflammatorystimulation of the pituitary- adrenocortical axis resulting in glucocorticoid secretion. In additionclinical data suggest important autocrine/paracrine pro-inflammatory roles for CRF in arthritis. Thuand/or block the effects of local overproduction of CRF at inflammatory sites may represent novel agof rheumatoid arthritis and other inflammatory conditions. A circulating form of a human binding profor CRF and the ability to inactivate CRF has been recently purified and cloned. The studies of theevaluating the potential anti-inflammatory effects of the human CRF-BP. The efficacy of CRF- BP willrat models of acute inflammation (carrageenin- and oyster-glycogen induced inflammation) and in twoarthritis (streptococcal cell wall- and adjuvant-induced arthritis). The study will also include pilout the best methodology for recombinant expression and purification of scale-up quantities of the Cthe development of assay systems for detection of immunoreactive and biologically active forms of thprotein. The second phase of the study will involve clinical studies to evaluate the anti-inflammatobinding protein in rheumatoid arthritis patients. In addition, orally active, small molecule non-pepantagonists will be identified as second generation agents for the treatment of rheumatoid arthritis

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.